comparemela.com

Latest Breaking News On - Alere san diego - Page 3 : comparemela.com

Boat Capsizes; Uber Driver Killed: San Diego County Police Log

Thank Share To request removal of your name from an arrest report, submitthese required itemstoarrestreports@patch.com. Boat Capsizes; Uber Driver Killed: San Diego County Police Log The rules of replying: Be respectful.This is a space for friendly local discussions. No racist, discriminatory, vulgar or threatening language will be tolerated. Be transparent.Use your real name, and back up your claims. Keep it local and relevant.Make sure your replies stay on topic.

Alere To Pay About $39 Mln For Selling Defective Blood Monitoring Devices

Alere To Pay About $39 Mln For Selling Defective Blood Monitoring Devices WASHINGTON (dpa-AFX) - Alere Inc. and Alere San Diego Inc. agreed to pay $38.75 million to settle allegations that the companies violated the False Claims Act by billing, and causing others to bill, the Medicare program for defective rapid point-of-care testing devices, the U.S. Department of Justice said. The settlement resolves allegations that, from 2008 to 2016, the Medical device manufacturers knowingly sold defective INRatio blood coagulation monitors used by Medicare beneficiaries taking anticoagulant drugs, such as warfarin. For those patients, blood coagulation monitoring is essential to determining a clinically appropriate and safe dosage for their medications. Too much of an anticoagulant drug can cause major bleeding, and too little of the drug can cause blood clots and strokes.

Alere Agrees To Pay $38 8M Over Blood Monitoring Device

ADVERTISEMENT Alere Agrees To Pay $38.8M Over Blood Monitoring Device Law360 (July 8, 2021, 10:18 PM EDT) Alere Inc. and Alere San Diego Inc. agreed to fork out $38.75 million to settle allegations that they violated the False Claims Act by billing Medicare for faulty blood-monitoring devices, the U.S. Department of Justice announced Thursday. The companies, acquired by Abbot in 2017, allegedly sold defective INRatio blood coagulation monitoring systems to Medicare beneficiaries from 2008 through 2016. The government alleged that since March 2008, Alere was aware that its INRatio system was capable of issuing incorrect results for patients due to an algorithm defect. Rather than correcting the alleged defect, Alere opted to close an investigation into the affected.

Pfizer to seek OK for third dose

Pfizer to seek OK for third dose
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.